mayo clinic glp-1 On the next episode of Aging Forward from Community Med: GLP-1s have made a big impact on the weight loss industry. But what do we need to consider when using them in older age?, Listen to A Mayo Clinic study found

Across both analyses, GLP-1 use was associated with significantly lower breast cancer incidence

Efficacy and Safety of Once-Weekly Semaglutide 1.0 mg vs Once-Daily Liraglutide 1.2 mg as Add-on to 1-3 Oral Antidiabetic Drugs in Subjects with Type 2 Diabetes (SUSTAIN 10) Diabetes Metab

The reductions in ROS and systemic inflammation, in combination with improvements in the other cardiometabolic parameters, are also thought to mediate the substantiated but so far formally unconfirmed kidney-protective effects of GLP-1 RAs, which may also directly or indirectly carry a HF-related benefit, considering that CKD is a prominent risk factor for HF (von Scholten et al., 2022)

Regular check-ins with your provider can also help maintain cardiometabolic benefits

Uncovering the link between albuminuria, CKD and DKD can lead to a better understanding of the pathophysiology of the disease and provide insight into the timing of adequate treatment with new drugs, such as SGLT2i, GLP-1RAs and or mineralocorticoid receptor antagonist